NeurAxis, Inc.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: US64134X2018

USD

2.71

-0.07 (-2.52%)

Dec 04

ASE

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

NeuroOne Medical Technologies Corp.

Singular Genomics Systems, Inc.

NeurAxis, Inc.

Nortech Systems, Inc.

PetVivo Holdings, Inc.

Sientra, Inc.

Acutus Medical, Inc.

Modular Medical, Inc.

PAVmed, Inc.

Check-Cap Ltd.

SmileDirectClub, Inc.

Why is NeurAxis, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

8.21%

EBIT Growth (5y)

-76.08%

EBIT to Interest (avg)

-3.65

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.86

Sales to Capital Employed (avg)

-0.56

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

21.35%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

18.73

EV to EBIT

-2.21

EV to EBITDA

-2.22

EV to Capital Employed

-10.57

EV to Sales

5.75

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-840.97%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

NET SALES(HY)

At USD 1.79 MM has Grown at 42.25%

NET PROFIT(HY)

Higher at USD -3.97 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 23.35 times

EPS(Q)

Highest at USD -0.22

-3What is not working for the Company

RAW MATERIAL COST(Y)

Grown by 5.05% (YoY

Here's what is working for NeurAxis, Inc.

Net Sales

At USD 1.79 MM has Grown at 42.25%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (USD MM)

Net Profit

Higher at USD -3.97 MM

than preceding 12 month period ended Jun 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

EPS

Highest at USD -0.22

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Debtors Turnover Ratio

Highest at 23.35 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for NeurAxis, Inc.

Raw Material Cost

Grown by 5.05% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales